Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. - Wikidata - wikimedia - TriplyDB

Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies.

Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies.

http://www.wikidata.org/entity/Q44444677

about

Pathogenesis of Helicobacter pylori infection Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial.Helicobacter pylori and extragastric diseases -- other helicobacters.The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial.Helicobacter pylori and extragastric diseases--other Helicobacters.Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model.Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.Functional mutations in and characterization of VHH against Helicobacter pylori urease.

P2860

Q24679810-9FE1C8FD-EE45-4C80-ACBF-A7D330AE7FCF Q26778023-3B2572AE-52CF-4125-986D-C31822CA0644 Q34938914-116ECBE4-B506-47C7-AEB2-947C23505C00 Q35583594-790B1BD1-516B-48E3-9025-815C479792CF Q35794384-A487B08A-9841-4CFF-910A-B83BA5729753 Q35878346-B6FEDB26-4EA6-4945-9FA7-7B36BC0D6FA5 Q37410270-EBD6A056-82BA-4B7B-A209-4B992CA1F75C Q42960962-D79B8ADD-787E-4FA0-B89C-ED2064E2713F Q45250904-032995B6-79C0-4DF1-A6D3-C1C1E59FF785 Q45265906-9D4328D2-8E80-4E22-A851-268B509FCD09

P2860

Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies.

http://www.wikidata.org/entity/Q44444677

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Prevention and suppression of ...... tion with specific antibodies.

@en

Prevention and suppression of ...... tion with specific antibodies.

@nl

type

label

Prevention and suppression of ...... tion with specific antibodies.

@en

Prevention and suppression of ...... tion with specific antibodies.

@nl

prefLabel

Prevention and suppression of ...... tion with specific antibodies.

@en

Prevention and suppression of ...... tion with specific antibodies.

@nl

P1433

Q44444677-6051360E-6B97-4188-807A-38CFC29F9FFE

P1476

Q44444677-4AE1225B-FC0D-422E-8866-90AD12B8828D

P2093

Q44444677-164334FC-02B8-43E5-8D6D-BF460488AC10

Q44444677-7AC93584-45E8-47F9-8A56-4ADCA2F15ECD

Q44444677-7E51774C-7603-487A-8014-2A6652171140

Q44444677-AC67058C-3160-4A69-956F-3E7BCE4F0E8B

Q44444677-DC403585-7EB6-4172-B025-8FBF555948B2

Q44444677-DF61CCAA-A8E5-4D16-8EBC-92602D756091

Q44444677-F313136E-42CF-4BB1-A83B-BF957C11DF24

Q44444677-FC40E0BD-7BD9-425F-BC3A-4A6436EF6C99

P2860

Q44444677-0A3D8E87-67D3-4238-BF0D-5C5E78571DF7

Q44444677-16F9CCA6-8A6C-4760-96F3-DE175FC1DA94

Q44444677-173780DC-BF85-421E-8639-95907C238A3B

Q44444677-18C2FB9B-CF9E-4AE1-A581-B42934FC4EC7

Q44444677-3BEC1F13-906D-4177-9FD3-89319C4523B2

Q44444677-5FDB013F-5A3D-42BD-8D41-DB0381AA6B99

Q44444677-6333087A-7CB1-4AAB-AABB-66C70DF51A98

Q44444677-82D515B7-A3C6-4E38-9FBC-3FF00E188A3D

Q44444677-923C528D-4E0B-42F6-8693-12A6FF95E2B7

Q44444677-9E1DC2E7-C3FE-4CCA-801A-70D4BDC8AE79

P304

Q44444677-53796B6E-AC37-4485-9247-0676EFDFFE0E

P31

Q44444677-BBE22B1A-2BA7-49C6-AE5E-64DE843B1314

P356

Q44444677-2750351C-E27B-4A71-898A-C2C0A3B1E99A

P433

Q44444677-8F6F1F14-AF3C-4F3C-AF89-69E199028371

P478

Q44444677-552F2AE4-2BD5-47DA-B721-FE91245746D1

P50

Q44444677-3754600C-FE53-44C2-A579-CECAD5E1614E

P577

Q44444677-DFB87A87-CA1C-4524-92B2-F47853A9A984

P5875

Q44444677-28B0F68C-09E2-46AA-9621-FDDADDF6B225

P698

Q44444677-7838CB62-27C0-4C85-9AB6-BB1462702CDE

P921

Q44444677-82645BCD-055D-4E81-9152-56BA83881B6B

P356

J.1523-5378.2003.00144.X

P1433

P1476

Prevention and suppression of ...... tion with specific antibodies.

@en

P2093

Eeva-Liisa Syväoja

http://www.w3.org/2001/XMLSchema#string

Hannu Korhonen

http://www.w3.org/2001/XMLSchema#string

Hilpi Rautelin

http://www.w3.org/2001/XMLSchema#string

Leena Rehnberg-Laiho

http://www.w3.org/2001/XMLSchema#string

Pertti Marnila

http://www.w3.org/2001/XMLSchema#string

Päivi Kärkkäinen

http://www.w3.org/2001/XMLSchema#string

Susanna Rokka

http://www.w3.org/2001/XMLSchema#string

Timo U Kosunen

http://www.w3.org/2001/XMLSchema#string

P2860

Metronidazole-resistant Helicobacter pylori

Passive immunity against human pathogens using bovine antibodies.

Helicobacter pylori: epidemiology and routes of transmission.

Preventing infectious disease with passive immunization.

The role of colostral antibodies in prevention of microbial infections.

Passive protection against diarrheal disease.

Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease.

Treatment failure of ofloxacin in Campylobacter pylori infection.

The presence of immunoglobulins in the gastric juice of patients infected with Helicobacter pylori is related to a reduced secretion of acid.

The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori.

P304

192-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1523-5378.2003.00144.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Marja-Liisa Hänninen

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10754525

http://www.w3.org/2001/XMLSchema#string

P698

12752731

http://www.w3.org/2001/XMLSchema#string

P921